{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:56:22Z","timestamp":1790139382252,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jval.2019.07.018","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T18:00:30Z","timestamp":1578506430000},"page":"104-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Concepts and Instruments for Patient-Reported Outcome Assessment in Celiac Disease: Literature Review and Experts\u2019 Perspectives"],"prefix":"10.1016","volume":"23","author":[{"given":"Sarah","family":"Clifford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliki Joanna","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skylar","family":"Fidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Drahos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Leffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jval.2019.07.018_bib1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/1521-4141(200105)31:5<1317::AID-IMMU1317>3.0.CO;2-I","article-title":"T\u00a0cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase","volume":"31","author":"Molberg","year":"2001","journal-title":"Eur J Immunol"},{"issue":"41","key":"10.1016\/j.jval.2019.07.018_bib2","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.3748\/wjg.v12.i41.6585","article-title":"Celiac disease","volume":"12","author":"Rodrigo","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jval.2019.07.018_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","article-title":"The Oslo definitions for coeliac disease and related terms","volume":"62","author":"Ludvigsson","year":"2013","journal-title":"Gut"},{"issue":"4-5","key":"10.1016\/j.jval.2019.07.018_bib4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.autrev.2014.01.043","article-title":"Diagnosis and classification of celiac disease and gluten sensitivity","volume":"13","author":"Tonutti","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jval.2019.07.018_bib5","doi-asserted-by":"crossref","first-page":"h4347","DOI":"10.1136\/bmj.h4347","article-title":"Celiac disease and non-celiac gluten sensitivity","volume":"351","author":"Lebwohl","year":"2015","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jval.2019.07.018_bib6","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ajg.2012.219","article-title":"The prevalence of celiac disease in the United States","volume":"107","author":"Rubio-Tapia","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jval.2019.07.018_bib7","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2015.01.044","article-title":"Celiac disease","volume":"135","author":"Green","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.jval.2019.07.018_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/jamapediatrics.2013.3858","article-title":"Celiac disease: a review","volume":"168","author":"Guandalini","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"5","key":"10.1016\/j.jval.2019.07.018_bib9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"American College of G. ACG clinical guidelines: diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.jval.2019.07.018_bib10","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s10620-016-4219-x","article-title":"Direct costs in patients with celiac disease in the USA: a retrospective claims analysis","volume":"61","author":"Guandalini","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jval.2019.07.018_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-230X-12-136","article-title":"Use of health care services and pharmaceutical agents in coeliac disease: a prospective nationwide study","volume":"12","author":"Ukkola","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.jval.2019.07.018_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MPG.0b013e31828ee55d","article-title":"Burden of illness and use of health care services before and after celiac disease diagnosis in children","volume":"57","author":"Mattila","year":"2013","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jval.2019.07.018_bib13","doi-asserted-by":"crossref","first-page":"e1337","DOI":"10.7717\/peerj.1337","article-title":"Gluten-free food database: the nutritional quality and cost of packaged gluten-free foods","volume":"3","author":"Missbach","year":"2015","journal-title":"PeerJ"},{"issue":"1081","key":"10.1016\/j.jval.2019.07.018_bib14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/postgradmedj-2015-133395","article-title":"Cost and availability of gluten-free food in the UK: in store and online","volume":"91","author":"Burden","year":"2015","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.jval.2019.07.018_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.dld.2008.05.011","article-title":"Quality of life in celiac disease patients: prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment","volume":"41","author":"Nachman","year":"2009","journal-title":"Dig Liver Dis"},{"issue":"22","key":"10.1016\/j.jval.2019.07.018_bib16","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.3748\/wjg.v16.i22.2780","article-title":"Anxiety and depression in adult patients with celiac disease on a gluten-free diet","volume":"16","author":"Hauser","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jval.2019.07.018_bib17","first-page":"241","article-title":"Quality of life in coeliac disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved","volume":"20","author":"Barratt","year":"2011","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"issue":"2","key":"10.1016\/j.jval.2019.07.018_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpsychores.2013.05.011","article-title":"Reduced quality of life in coeliac disease is more strongly associated with depression than gastrointestinal symptoms","volume":"75","author":"Sainsbury","year":"2013","journal-title":"J\u00a0Psychosom Res"},{"issue":"2","key":"10.1016\/j.jval.2019.07.018_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jpsychores.2012.11.007","article-title":"Coeliac disease, diet adherence and depressive symptoms","volume":"74","author":"van Hees","year":"2013","journal-title":"J\u00a0Psychosom Res"},{"issue":"4","key":"10.1016\/j.jval.2019.07.018_bib20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gut.2009.195131","article-title":"Classification and management of refractory coeliac disease","volume":"59","author":"Rubio-Tapia","year":"2010","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jval.2019.07.018_bib21","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1038\/ctg.2016.70","article-title":"Outcome of referrals for non-responsive celiac disease in a tertiary center: low incidence of refractory celiac disease in the Netherlands","volume":"8","author":"van Wanrooij","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"10.1016\/j.jval.2019.07.018_bib22","first-page":"197","article-title":"Treatment failure in coeliac disease: a practical guide to investigaion and treatment of non-responsive and refractory coeliac disease","volume":"21","author":"Mooney","year":"2012","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"issue":"4","key":"10.1016\/j.jval.2019.07.018_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2006.12.006","article-title":"Etiologies and predictors of diagnosis in nonresponsive celiac disease","volume":"5","author":"Leffler","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jval.2019.07.018_bib24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/apt.13755","article-title":"Creation of a meodel to predict survival in patients with refractory coeliac disease using a multinational registry","volume":"44","author":"Rubio-Tapia","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jval.2019.07.018_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.gtc.2018.09.010","article-title":"Refractory celiac disease","volume":"48","author":"Malamut","year":"2019","journal-title":"Gastroenterol Clin North Am"},{"issue":"2","key":"10.1016\/j.jval.2019.07.018_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/gastro\/gov006","article-title":"Development of drugs for celiac disease: review of endpoints for phase 2 and 3 trials","volume":"3","author":"Gottlieb","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"8","key":"10.1016\/j.jval.2019.07.018_bib27","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/gutjnl-2017-314853","article-title":"Outcome measures in coeliac disease trials: the Tampere recommendations","volume":"67","author":"Ludvigsson","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jval.2019.07.018_bib28","series-title":"Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims","author":"US Food and Drug Administration","year":"2009"},{"key":"10.1016\/j.jval.2019.07.018_bib29","series-title":"Reflection Paper on the Regulatory Guidance for the Use of Health-Related Quality of Life (HRQL) Measures in the Evaluation of Medicinal Products","year":"2005"},{"issue":"3","key":"10.1016\/j.jval.2019.07.018_bib30","doi-asserted-by":"crossref","first-page":"A275","DOI":"10.1016\/j.jval.2016.03.1962","article-title":"Outcome assessments of primary endpoints of new drugs approved by the FDA (2011-2015)","volume":"19","author":"Gnanasakthy","year":"2016","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2019.07.018_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jegh.2015.04.006","article-title":"Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe (2008-2012)","volume":"5","author":"Bansal","year":"2015","journal-title":"J\u00a0Epidemiol Glob Health"},{"issue":"4","key":"10.1016\/j.jval.2019.07.018_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/apt.13703","article-title":"Systematic review: patient-reported outcome measures in coeliac disease for regulatory submissions","volume":"44","author":"Canestaro","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jval.2019.07.018_bib33","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/apt.14942","article-title":"Quality of life in coeliac disease: item reduction, scale development and psychometric evaluation of the Coeliac Disease Assessment Questionnaire (CDAQ)","volume":"48","author":"Crocker","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jval.2019.07.018_bib34","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-277X.2011.01170.x","article-title":"Impact of coeliac disease on dietary habits and quality of life","volume":"24","author":"Black","year":"2011","journal-title":"J\u00a0Hum Nutr Diet"},{"issue":"16","key":"10.1016\/j.jval.2019.07.018_bib35","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/mds.22821","article-title":"Neurological symptoms in patients with biopsy proven celiac disease","volume":"24","author":"Burk","year":"2009","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.jval.2019.07.018_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10072-003-0181-4","article-title":"Clinical and neurological abnormalities in adult celiac disease","volume":"24","author":"Cicarelli","year":"2003","journal-title":"Neurol Sci"},{"issue":"11","key":"10.1016\/j.jval.2019.07.018_bib37","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1007\/s10620-010-1342-y","article-title":"Psychosocial factors are more important than disease activity in determining gastrointestinal symptoms and health status in adults at a celiac disease referral center","volume":"55","author":"Dorn","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.jval.2019.07.018_bib38","first-page":"78","article-title":"Gastrointestinal and non-gastrointestinal presentation in patients with celiac disease","volume":"16","author":"Ehsani-Ardakani","year":"2013","journal-title":"Arch Iran Med"},{"issue":"12","key":"10.1016\/j.jval.2019.07.018_bib39","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/00042737-200312000-00006","article-title":"Affective disorders and quality of life in adult coeliac disease patients on a gluten-free diet","volume":"15","author":"Fera","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jval.2019.07.018_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1472-6963-10-105","article-title":"Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey","volume":"10","author":"Gray","year":"2010","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"10.1016\/j.jval.2019.07.018_bib41","doi-asserted-by":"crossref","first-page":"E429","DOI":"10.3390\/nu8070429","article-title":"Gastrointestinal symptoms in celiac disease patients on a long-term gluten-free diet","volume":"8","author":"Laurikka","year":"2016","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.jval.2019.07.018_bib42","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.meg.0000221855.19201.e8","article-title":"Health-related quality of life in adult coeliac disease in Germany: results of a national survey","volume":"18","author":"Hauser","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.jval.2019.07.018_bib43","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/MEG.0000000000000709","article-title":"Symptoms and biomarkers associated with celiac disease: evaluation of a population-based screening program in adults","volume":"28","author":"Karhus","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jval.2019.07.018_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/egh.10.81","article-title":"Celiac disease and health-related quality of life","volume":"5","author":"Kurppa","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.jval.2019.07.018_bib45","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jada.2003.08.027","article-title":"Celiac diet: its impact on quality of life","volume":"103","author":"Lee","year":"2003","journal-title":"J\u00a0Am Diet Assoc"},{"issue":"2","key":"10.1016\/j.jval.2019.07.018_bib46","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1021956200382","article-title":"Changing presentation of adult celiac disease","volume":"48","author":"Lo","year":"2003","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.jval.2019.07.018_bib47","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3390\/nu5051585","article-title":"Is dietitian use associated with celiac disease outcomes?","volume":"5","author":"Mahadev","year":"2013","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.jval.2019.07.018_bib48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/ajcn\/79.4.669","article-title":"Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease","volume":"79","author":"Murray","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.jval.2019.07.018_bib49","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cgh.2010.06.017","article-title":"Gastroesophageal reflux symptoms in patients with celiac disease and the effects of a gluten-free diet","volume":"9","author":"Nachman","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jval.2019.07.018_bib50","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-230X-13-75","article-title":"Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study","volume":"13","author":"Paarlahti","year":"2013","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.jval.2019.07.018_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11845-011-0788-z","article-title":"Adult coeliac disease in Ireland: a case series","volume":"181","author":"Saleem","year":"2012","journal-title":"Ir J Med Sci"},{"issue":"5","key":"10.1016\/j.jval.2019.07.018_bib52","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2036.2005.02619.x","article-title":"Fatigue in adult coeliac disease","volume":"22","author":"Siniscalchi","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jval.2019.07.018_bib53","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cgh.2010.10.011","article-title":"Diet improves perception of health and well-being in symptomatic, but not asymptomatic, patients with celiac disease","volume":"9","author":"Ukkola","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jval.2019.07.018_bib54","first-page":"17","article-title":"Patients\u2019 experiences and perceptions of living with coeliac disease\u2014implications for optimizing care","volume":"21","author":"Ukkola","year":"2012","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"issue":"10","key":"10.1016\/j.jval.2019.07.018_bib55","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1365-2036.2009.03983.x","article-title":"Patient perceptions of the burden of coeliac disease and its treatment in the UK","volume":"29","author":"Whitaker","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jval.2019.07.018_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-277X.2006.00659.x","article-title":"The impact of a gluten-free diet on adults with coeliac disease: results of a national survey","volume":"19","author":"Zarkadas","year":"2006","journal-title":"J\u00a0Hum Nutr Diet"},{"issue":"8","key":"10.1016\/j.jval.2019.07.018_bib57","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1365-2036.2010.04432.x","article-title":"The quality of sleep in patients with coeliac disease","volume":"32","author":"Zingone","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jval.2019.07.018_bib58","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/S1590-8658(12)60447-2","article-title":"Prospective evaluation of the quality of sleep in celiac patients","volume":"44","author":"Zingone","year":"2012","journal-title":"Digestive Liver Disease"},{"issue":"1","key":"10.1016\/j.jval.2019.07.018_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3748\/wjg.14.46","article-title":"Factors that impact health-related quality of life in adults with celiac disease: a multicenter study","volume":"14","author":"Casellas","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jval.2019.07.018_bib60","doi-asserted-by":"crossref","first-page":"A595","DOI":"10.1016\/j.jval.2016.09.1429","article-title":"The Coeliac Disease Assessment Questionnaire (Cdaq): development of a patient-reported outcome measure","volume":"19","author":"Crocker","year":"2016","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jval.2019.07.018_bib61","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial","volume":"148","author":"Leffler","year":"2015","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.jval.2019.07.018_bib62","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.cgh.2009.07.031","article-title":"A\u00a0validated disease-specific symptom index for adults with celiac disease","volume":"7","author":"Leffler","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jval.2019.07.018_bib63","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ajg.2014.29","article-title":"Patient perception of treatment burden is high in celiac disease compared with other common conditions","volume":"109","author":"Shah","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jval.2019.07.018_bib64","first-page":"125","article-title":"Payer perspectives on patient-reported outcomes in health care decision making: oncology examples","volume":"23","author":"Brogan","year":"2017","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"1","key":"10.1016\/j.jval.2019.07.018_bib65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12955-016-0529-0","article-title":"Incorporating development of a patient-reported outcome instrument in a clinical drug development program: examples from a heart failure program","volume":"14","author":"Wiklund","year":"2016","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2019.07.018_bib66","doi-asserted-by":"crossref","first-page":"S603","DOI":"10.14309\/00000434-201210001-01509","article-title":"Celiac disease symptom frequency and severity using a disease-specific patient-reported outcome diary: observations from a psychometric validation study in 202 patients","volume":"107","author":"Adelman","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jval.2019.07.018_bib67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.mcg.0000225516.05666.4e","article-title":"Development and validation of the Celiac Disease Questionnaire (CDQ), a disease-specific health-related quality of life measure for adult patients with celiac disease","volume":"41","author":"Hauser","year":"2007","journal-title":"J\u00a0Clin Gastroenterol"}],"updated-by":[{"DOI":"10.1016\/j.jval.2020.02.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000}}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519323423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519323423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T17:52:21Z","timestamp":1722275541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301519323423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1098301519323423"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2019.07.018","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concepts and Instruments for Patient-Reported Outcome Assessment in Celiac Disease: Literature Review and Experts\u2019 Perspectives","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2019.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}